Bronchoalveolar cellular analysis in scleroderma lung disease: does Sutton's law hold?
Baughman
Robert P
RP
Raghu
Ganesh
G
D001992:Bronchoalveolar Lavage Fluid / Q000276:immunology*; D003520:Cyclophosphamide / Q000627:therapeutic use; D004804:Eosinophils / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects / Q000276:immunology*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007958:Leukocyte Count; D009504:Neutrophils / Q000276:immunology; D011658:Pulmonary Fibrosis / Q000188:drug therapy / Q000276:immunology*; D012595:Scleroderma, Systemic / Q000188:drug therapy / Q000276:immunology*; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D003520:Cyclophosphamide